Catheter-related Bloodstream Infection
📧 Sign up to get email alerts when something new happens for Catheter-related Bloodstream Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection [Phase 3]
A Phase 3 study evaluated the safety and effectiveness of a taurolidine-citrate catheter lock solution to prevent bloodstream infections in …
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Effect of Vancomycin After Catheter Replacement [Phase 4]
Clinical trial update on vancomycin after catheter replacement for central line-associated bloodstream infections (CLABSI) in Phase 4.
-
CLINICAL_TRIALS research · 2018-05-29Clinical Trial Update: Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters. [Phase 4]
Phase 4 trial comparing Taurolock Hep 500 versus unfractionated heparin as an anti-inflammatory strategy for hemodialysis catheters; the tri…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition [Phase 1, Phase 2]
A Phase 1/2 trial evaluating prophylactic ethanol lock therapy to prevent catheter-related bloodstream infections in home parenteral nutriti…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Catheter Salvage in Intestinal Failure Patients
A completed clinical trial from Rigshospitalet, Denmark evaluated catheter salvage strategies in intestinal failure patients with catheter-r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Bacteremia Among Hemodialysis Patients
This completed clinical trial evaluated whether procalcitonin levels could serve as a surrogate biomarker for catheter-related bloodstream i…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Long-term Hemodialysis Catheter Removal and Delayed Replacement, Versus Exchange Over a Guidewire to Treat Catheter Related Blood Stream Infection [NA]
A completed clinical trial comparing long-term hemodialysis catheter removal with delayed replacement versus exchange over a guidewire for c…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: High-Flow Needleless Valve and DualCap Disinfection Devices Associate With Catheter-related Bloodstream Infection [Phase 4]
A Phase 4 clinical trial update reports that use of a High-Flow Needleless Valve and the DualCap Disinfection Device is associated with cath…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Clinical Trial With Catheter Locking TauroSept® (Taurolidine 2%) or Saline Solution 0,9% [NA]
A completed clinical trial comparing TauroSept, a taurolidine 2% catheter locking solution, with normal saline for preventing catheter-relat…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction [Phase 4]
Phase 4 trial comparing TauroLock-based catheter lock regimen with 4% citrate in tunneled hemodialysis catheters to prevent bacteremia and c…
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci [NA]
A clinical trial update describing a randomized, multicenter study to evaluate ethanol lock solution for curative treatment of implantable v…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Clinical Trial Comparing Catheter Lock Solutions TaurolockTMHep 100 and Heparin 100 IE/ml. [Phase 4]
A phase 4 clinical trial compares Taurolock Hep 100 with heparin 100 IE/mL as catheter lock solutions to prevent catheter-related bloodstrea…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Pediatric Ethanol Lock Therapy Study. [NA]
Clinical trial update on pediatric ethanol lock therapy aimed at preventing catheter-related infections. The study, sponsored by the Univers…
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: Treatment of Hemodialysis Catheter-Related Bacteremia [Phase 2, Phase 3]
Clinical trial evaluating treatment for catheter-related bloodstream infection in patients on hemodialysis (Phase 2/Phase 3) has been withdr…
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus. [Phase 3]
Phase 3 trial evaluating short-term sequential therapy for non-complicated catheter-related bloodstream infection due to methicillin-suscept…
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children [Phase 4]
Phase 4 clinical trial comparing heparin versus taurolidine to prevent catheter-related bloodstream infections in children; the current stat…
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: Concentration of Antimicrobials in Catheter-lock Solutions [Phase 4]
Phase 4 clinical trial update evaluating the concentration of antimicrobials in catheter-lock solutions for preventing catheter-related infe…
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Efficacy and Safety of Ethanol Lock Solution in Prevention of Catheter Related Bloodstream Infection for Patients Suffering Acute Renal Failure, and Hospitalized in Intensive Care Unit. A Multi-Center, Randomized, Versus Placebo, Double Blinded Clinical Trial [Phase 3]
Phase 3 randomized, double-blind trial evaluating ethanol lock solution to prevent catheter-related bloodstream infection in ICU patients wi…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
A completed clinical trial comparing infection rates between two catheter access devices. The study evaluated catheter-related bloodstream i…
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: Reducing Catheter-Related Bloodstream Infections in the ICU With a Chlorhexidine-Impregnated Sponge (BIOPATCH) [Phase 4]
Phase 4 trial evaluating BIOPATCH, a chlorhexidine-impregnated sponge, for reducing catheter-related bloodstream infections in ICU patients;…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization [Phase 3]
A Phase 3 trial assessing the safety and efficacy of the Angiotech Central Venous Catheter to prevent bacterial catheter colonization has co…
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections [Phase 3]
A Phase 3 trial evaluating Linezolid for catheter-related Gram-positive bloodstream infections in hemodialysis patients was terminated, with…
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: AgION Catheter for Preventing Catheter-Related Bloodstream Infections [NA]
This update notes the completion of a trial evaluating AgION-coated catheters to prevent catheter-related bloodstream infections.
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Trial on the Efficacy of Tegaderm Chlorhexidine Gluconate (CHG) in Reducing Catheter Related Bloodstream Infections [Phase 4]
A Phase 4 clinical trial evaluating Tegaderm CHG dressing for reducing catheter-related bloodstream infections, with status currently unknow…
-
CLINICAL_TRIALS research · 2011-02-23Clinical Trial Update: Evaluating Central Line Hub Contamination Using a Novel Capping Device [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/Phase 2 study evaluating a novel central line hub capping device to prevent hub contaminatio…